Trial intelligence / Profile preview

Mechanisms of UCB-MSCs in Knee Osteoarthritis

NCT06078059Completed

Sponsor
University Medical Centre Ljubljana
Start
Nov 2022
Primary completion
Oct 2024
Countries
1
01

Overview

Randomised, open-label trial in osteoarthritis (OA) (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoints: Soluble biomarkers analysis with multiplex bead-based immunoassays Luminex in synovial fluid, Biomarkers analysis with Enzyme-linked immunosorbent assay (ELISA) in synovial fluid and 1 more. Started Nov 2022; status: completed.

02

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT06078059.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06078059.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call